Group 1 - The FDA is phasing out animal testing, which is a positive development for companies like Certara that operate in the bio simulation space [1] - There is a notable increase in GDX, indicating a bullish trend in the market [1] - The Russell 2000 index is experiencing a delay in performance, showing signs of a massive triple top formation, suggesting potential selling opportunities for IWM [1]